FIBROGEN INC — Director's Dealing 2022

Jun 24, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2022-06-22

Reporting Person: Wettig Thane (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-22	Common Stock	F	655	$11.42	Disposed	91294	Direct

Footnotes

F1: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.

F2: Includes 1,988 shares acquired on May 13, 2022 through the Issuer's Employee Stock Purchase Plan.